{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:25:48Z","timestamp":1740122748304,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11030-015-9617-z","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T04:49:57Z","timestamp":1437626997000},"page":"55-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human $$\\mathbf{A}_{3}$$ A 3 adenosine receptor ligands"],"prefix":"10.1007","volume":"20","author":[{"given":"Liane","family":"Sa\u00edz-Urra","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9833-134X","authenticated-orcid":false,"given":"Marta","family":"Teijeira","sequence":"additional","affiliation":[]},{"given":"Virginia","family":"Rivero-Buceta","sequence":"additional","affiliation":[]},{"given":"Aliuska Morales","family":"Helguera","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Celeiro","sequence":"additional","affiliation":[]},{"given":"M\u00aa Carmen","family":"Ter\u00e1n","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Besada","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"9617_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247\u2013264. doi: 10.1038\/nrd1983","journal-title":"Nat Rev Drug Discov"},{"key":"9617_CR2","doi-asserted-by":"crossref","unstructured":"Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552. doi: 10.1124\/pr.110.003285","DOI":"10.1124\/pr.110.003285"},{"key":"9617_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/med.20254","volume":"33","author":"SL Cheong","year":"2013","unstructured":"Cheong SL, Federico S, Venkatesan G, Mandel AL, Shao YM, Moro S, Spalluto G, Pastorin G (2013) The adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches. Med Res Rev 33:235\u2013335. doi: 10.1002\/med.20254","journal-title":"Med Res Rev"},{"key":"9617_CR4","doi-asserted-by":"crossref","unstructured":"Borea PA, Gessi S, Bar-Yehuda S, Fishman P (2009) $${\\rm A}_{3}$$ A 3 adenosine receptor: pharmacology and role in disease. Handb Exp Pharmacol 193:297\u2013327. doi: 10.1007\/978-3-540-89615-9_10","DOI":"10.1007\/978-3-540-89615-9_10"},{"key":"9617_CR5","doi-asserted-by":"crossref","unstructured":"Wang J, Drake L, Sajjadi F, Firestein GS, Mullane KM, Bullough DA (1997) Dual activation of adenosine $${\\rm A}_{1}$$ A 1 and $${\\rm A}_{3}$$ A 3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol 320:241\u2013248. doi: 10.1016\/S0014-2999(96)00901-6","DOI":"10.1016\/S0014-2999(96)00901-6"},{"key":"9617_CR6","doi-asserted-by":"crossref","first-page":"G401","DOI":"10.1152\/ajpgi.00454.2007","volume":"294","author":"VL Kolachala","year":"2008","unstructured":"Kolachala VL, Bajaj R, Chalasani M, Sitaraman SV (2008) Purinergic receptors in gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 294:G401\u2013410. doi: 10.1152\/ajpgi.00454.2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9617_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1124\/jpet.107.127480","volume":"324","author":"TC Wan","year":"2008","unstructured":"Wan TC, Ge ZD, Tampo A, Mio Y, Bienengraeber MW, Tracey WR, Gross GJ, Kwok WM, Auchampach JA (2008) The $$\\text{ A }_{3}$$ A 3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3\u2019-aminoadenosine-5\u2019-N-methylcarboxamide] protects against myocardial ischemia\/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 324:234\u2013243. doi: 10.1124\/jpet.107.127480","journal-title":"J Pharmacol Exp Ther"},{"key":"9617_CR8","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1158\/1078-0432.CCR-03-0651","volume":"10","author":"L Madi","year":"2004","unstructured":"Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F, Fishman P (2004) The $$\\text{ A }_{3}$$ A 3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10:4472\u20134479. doi: 10.1158\/1078-0432.CCR-03-0651","journal-title":"Clin Cancer Res"},{"key":"9617_CR9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728214.12.3.479","volume":"12","author":"ZG Gao","year":"2007","unstructured":"Gao ZG, Jacobson KA (2007) Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 12:479\u2013492. doi: 10.1517\/14728214.12.3.479","journal-title":"Expert Opin Emerg Drugs"},{"key":"9617_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1527-3466.2006.00227.x","volume":"24","author":"Z Xu","year":"2006","unstructured":"Xu Z, Jang Y, Mueller RA, Norfleet EA (2006) IB-MECA and cardioprotection. Cardiovasc Cardiovasc Drug Rev 24:227\u2013238. doi: 10.1111\/j.1527-3466.2006.00227.x","journal-title":"Cardiovasc Cardiovasc Drug Rev"},{"key":"9617_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/1568026033392174","volume":"3","author":"CE M\u00fcller","year":"2003","unstructured":"M\u00fcller CE (2003) Medicinal chemistry of adenosine $$\\text{ A }_{3}$$ A 3 receptor ligands. Curr Top Med Chem 3:445\u2013462. doi: 10.2174\/1568026033392174","journal-title":"Curr Top Med Chem"},{"key":"9617_CR12","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2174\/092986706777935302","volume":"13","author":"MP Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Helguera AM (2006) Quantitative structure activity relationships as useful tools for the design of new adenosine receptor ligands 1. Agonist. Curr Med Chem 13:2253\u20132266. doi: 10.2174\/092986706777935195","journal-title":"Curr Med Chem"},{"key":"9617_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/138955708783744128","volume":"8","author":"E Estrada","year":"2008","unstructured":"Estrada E (2008) How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design. Mini Rev Med Chem 8:213\u2013221. doi: 10.2174\/138955708783744128","journal-title":"Mini Rev Med Chem"},{"key":"9617_CR14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ejmech.2008.09.022","volume":"44","author":"S Sharma","year":"2009","unstructured":"Sharma S, Sharma BK, Sharma SK, Singh P, Prabhakar YS (2009) Topological descriptors in modeling the agonistic activity of human $$\\text{ A }_{3}$$ A 3 adenosine receptor ligands: the derivatives of 2-chloro-N(6)-substituted-4 $$^{\\prime }$$ \u2032 -thioadenosine-5 $$^{\\prime }$$ \u2032 -uronamide. Eur J Med Chem 44:1377\u20131382. doi: 10.1016\/j.ejmech.2008.09.022","journal-title":"Eur J Med Chem"},{"key":"9617_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jps.20449","volume":"95","author":"MA Cabrera","year":"2006","unstructured":"Cabrera MA, Gonz\u00e1lez I, Fern\u00e1ndez C, Navarro C, Bermejo MA (2006) A topological substructural approach for the prediction of P-glycoprotein substrates. J Pharm Sci 95:589\u2013606. doi: 10.1002\/jps.20449","journal-title":"J Pharm Sci"},{"key":"9617_CR16","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2174\/138161210792389243","volume":"16","author":"E Estrada","year":"2010","unstructured":"Estrada E, Molina E, Nodarse D, Uriarte E (2010) Structural contributions of substrates to their binding to P-glycoprotein. A TOPS-MODE approach. Curr Pharm Des 16:2676\u20132709. doi: 10.2174\/138161210792389243","journal-title":"Curr Pharm Des"},{"key":"9617_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2011.12.030","volume":"49","author":"A P\u00e9rez-Garrido","year":"2012","unstructured":"P\u00e9rez-Garrido A, Helguera AM, Ruiz JM, Rentero PZ (2012) Topological sub-structural molecular design approach: radical scavenging activity. Eur J Med Chem 49:86\u201394. doi: 10.1016\/j.ejmech.2011.12.030","journal-title":"Eur J Med Chem"},{"key":"9617_CR18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1039\/b718860a","volume":"10","author":"A Garcia-Lorenzo","year":"2008","unstructured":"Garcia-Lorenzo A, Tojo E, Tojo J, Teijeira M, Rodriguez-Berrocal FJ, Gonz\u00e1lez MP, Martinez-Zorzano VS (2008) Cytotoxicity of selected imidazolium-derived ionic liquids in the human Caco-2 cell line. Sub-structural toxicological interpretation through a QSAR study. Green Chem 10:508\u2013516. doi: 10.1039\/B718860A","journal-title":"Green Chem"},{"key":"9617_CR19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bmc.2004.10.063","volume":"13","author":"MP Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Fall Y, Teijeira M, Besada P (2005) A radial distribution function approach to predict $$\\text{ A }_{\\rm 2B}$$ A 2 B agonist effect of adenosine analogues. Bioorg Med Chem 13:601\u2013608. doi: 10.1016\/j.bmc.2004.10.063","journal-title":"Bioorg Med Chem"},{"key":"9617_CR20","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.bmcl.2005.03.028","volume":"15","author":"MP Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Besada P (2005) Geometry, topology, and atom-weights assembly descriptors to predicting $$\\text{ A }_{1}$$ A 1 adenosine receptors agonists. Bioorg Med Chem Lett 15:2641\u20132645. doi: 10.1016\/j.bmcl.2005.03.028","journal-title":"Bioorg Med Chem Lett"},{"key":"9617_CR21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ejmech.2005.04.014","volume":"40","author":"MP Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Gonz\u00e1lez-Moa MJ (2005) GETAWAY descriptors to predicting $$\\text{ A }_{\\rm 2A}$$ A 2 A adenosine receptors agonists. Eur J Med Chem 40:1080\u20131086. doi: 10.1016\/j.ejmech.2005.04.014","journal-title":"Eur J Med Chem"},{"key":"9617_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2005.08.004","volume":"41","author":"MP Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Helguera AM (2006) Radial distribution function descriptors: an alternative for predicting $$\\text{ A }_{\\rm 2A}$$ A 2 A adenosine receptors agonists. Eur J Med Chem 41:56\u201362. doi: 10.1016\/j.ejmech.2005.08.004","journal-title":"Eur J Med Chem"},{"key":"9617_CR23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bmc.2007.11.026","volume":"16","author":"MP Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez MP, Besada P, Gonz\u00e1lez Moa MJ, Teijeira M, Ter\u00e1n C (2008) New QSAR combined strategy for the design of $$\\text{ A }_{1}$$ A 1 adenosine receptor agonists. Bioorg Med Chem 16:1658\u20131675. doi: 10.1016\/j.bmc.2007.11.026","journal-title":"Bioorg Med Chem"},{"key":"9617_CR24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1747-0285.2010.00971.x","volume":"75","author":"M Cruz-Monteagudo","year":"2010","unstructured":"Cruz-Monteagudo M, Cordeiro MN, Teijeira M, Gonz\u00e1lez MP, Borges F (2010) Multidimensional drug design: simultaneous analysis of binding and relative efficacy profiles of N6-substituted-4-thioadenosines $$\\text{ A }_{3}$$ A 3 adenosine receptor agonists. Chem Biol Drug Des 75:607\u2013618. doi: 10.1111\/j.1747-0285.2010.00971.x","journal-title":"Chem Biol Drug Des"},{"key":"9617_CR25","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1021\/ci300516w","volume":"53","author":"I Bonet","year":"2013","unstructured":"Bonet I, Franco-Montero P, Rivero V, Teijeira M, Borges F, Uriarte E, Helguera Morales (2013) A classifier ensemble based on feature selection and diversity measures for predicting the affinity of $$\\text{ A }_{\\rm 2B}$$ A 2 B Adenosine receptor antagonists. J Chem Inf Model 53:3140\u20133155. doi: 10.1021\/ci300516w","journal-title":"J Chem Inf Model"},{"key":"9617_CR26","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmcl.2005.05.122","volume":"15","author":"MP Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Besada P, Gonz\u00e1lez-Moa MJ (2005) BCUT descriptors for predicting affinity toward $$\\text{ A }_{3}$$ A 3 adenosine receptors. Bioorg Med Chem Lett 15:3491\u20133495. doi: 10.1016\/j.bmcl.2005.05.122","journal-title":"Bioorg Med Chem Lett"},{"key":"9617_CR27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bmcl.2005.11.063","volume":"16","author":"MP Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M (2006) A topological function based on spectral moments for predicting affinity toward $$\\text{ A }_{3}$$ A 3 adenosine receptors. Bioorg Med Chem Lett 16:1291\u20131296. doi: 10.1016\/j.bmcl.2005.11.063","journal-title":"Bioorg Med Chem Lett"},{"key":"9617_CR28","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/jm981090+","volume":"42","author":"EW Tilburg van","year":"1999","unstructured":"van Tilburg EW, von Frijtag Drabbe K\u00fcnzel J, de Groote M, Vollinga RC, Lorenzen A, IJzerman AP (1999) N6,5\u2019-Disubstituted adenosine derivatives as partial agonists for the human adenosine $$\\text{ A }_{3}$$ A 3 receptor. J Med Chem 42:1393\u20131400. doi: 10.1021\/jm981090+","journal-title":"J Med Chem"},{"key":"9617_CR29","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/S0960-894X(00)00415-7","volume":"10","author":"MJ Wanner","year":"2000","unstructured":"Wanner MJ, JK Von Frijtag Drabbe K\u00fcnzel, Ijzerman AP, Koomen GJ (2000) 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine $$\\text{ A }_{1}$$ A 1 , $$\\text{ A }_{\\rm 2A}$$ A 2 A and $$\\text{ A }_{3}$$ A 3 receptor subtypes. Bioorg Med Chem Lett 10:2141\u20132144. doi: 10.1016\/S0960-894X(00)00415-7","journal-title":"Bioorg Med Chem Lett"},{"key":"9617_CR30","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0968-0896(03)00123-8","volume":"11","author":"EW Tilburg van","year":"2003","unstructured":"van Tilburg EW, Gremmen M, von Frijtag Drabbe K\u00fcnzel J, de Groote M, IJzerman AP (2003) 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine $$\\text{ A }_{\\rm 2A}$$ A 2 A receptor. Bioorg Med Chem 11:2183\u20132192. doi: 10.1016\/S0968-0896(03)00123-8","journal-title":"Bioorg Med Chem"},{"key":"9617_CR31","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1021\/jm001114o","volume":"44","author":"EW Tilburg van","year":"2001","unstructured":"van Tilburg EW, van der Klein PA, von Frijtag Drabbe K\u00fcnzel J, de Groote M, Stannek C, Lorenzen A, IJzerman AP (2001) 5\u2019-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine $$\\text{ A }_{1}$$ A 1 and $$\\text{ A }_{3}$$ A 3 receptors. J Med Chem 44:2966\u20132975. doi: 10.1021\/jm001114o","journal-title":"J Med Chem"},{"key":"9617_CR32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/jm010952v","volume":"45","author":"EW Tilburg van","year":"2002","unstructured":"van Tilburg EW, von Frijtag Drabbe Kunzel J, de Groote M, IJzerman AP (2002) 2,5\u2019-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine $$\\text{ A }_{1}$$ A 1 , $$\\text{ A }_{\\rm 2A}$$ A 2 A , and $$\\text{ A }_{3}$$ A 3 receptor. J Med Chem 45:420\u2013429. doi: 10.1021\/jm010952v","journal-title":"J Med Chem"},{"key":"9617_CR33","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/jm021074j","volume":"46","author":"MW Beukers","year":"2003","unstructured":"Beukers MW, Wanner MJ, Von Frijtag Drabbe K\u00fcnzel JK, Klaasse EC, IJzerman AP, Koomen GJ (2003) $$\\text{ N }^{6}$$ N 6 -cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine $$\\text{ A }_{1}$$ A 1 receptor. J Med Chem 46:1492\u20131503. doi: 10.1021\/jm021074j","journal-title":"J Med Chem"},{"key":"9617_CR34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-2299(200002)49:2<85::AID-DDR2>3.0.CO;2-W","volume":"49","author":"M Zwart de","year":"2000","unstructured":"de Zwart M, de Groote M, van der Klein PAM, van Dun R, Bronsing R, Jacobien K, von Frijtag Drabbe Kunzel J, Ijzerman AP (2000) Phenyl-substituted $$\\text{ N }^{6}$$ N 6 -Phenyladenosines and $$\\text{ N }^{6}$$ N 6 -Phenyl-5 $$^{\\prime }$$ \u2032 -N-Ethylcarboxamidoadenosines with high activity at human adenosine $$\\text{ A }_{\\rm 2B}$$ A 2 B receptors. Drug Dev Res 49:85\u201393. doi: 10.1002\/(SICI)1098-2299(200002)49:23.0.CO;2-W","journal-title":"Drug Dev Res"},{"key":"9617_CR35","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm9905965","volume":"43","author":"KA Jacobson","year":"2000","unstructured":"Jacobson KA, Ji X, Li AH, Melman N, Siddiqui MA, Shin KJ, Marquez VE, Ravi RG (2000) Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J Med Chem 43:2196\u20132203. doi: 10.1021\/jm9905965","journal-title":"J Med Chem"},{"key":"9617_CR36","unstructured":"STATISTICA (Data Analysis Software System), Version 12 StatSoft Inc:Tulsa"},{"key":"9617_CR37","volume-title":"Multivariate analysis: methods and applications","author":"WR Dillon","year":"1984","unstructured":"Dillon WR, Goldstein M (1984) Multivariate analysis: methods and applications. Wiley, New York"},{"key":"9617_CR38","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bmc.2008.12.055","volume":"17","author":"MS Bhatia","year":"2009","unstructured":"Bhatia MS, Ingale KB, Choudhari PB, Bhatia NM, Sawant RL (2009) Application quantum and physico chemical molecular descriptors utilizing principal components to study mode of anticoagulant activity of pyridyl chromen-2-one derivatives. Bioorg Med Chem 17:1654\u20131662. doi: 10.1016\/j.bmc.2008.12.055","journal-title":"Bioorg Med Chem"},{"key":"9617_CR39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.aca.2009.05.003","volume":"646","author":"B Hemmateenejad","year":"2009","unstructured":"Hemmateenejad B, Elyasi M (2009) A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling. Anal Chim Acta 646:30\u201338. doi: 10.1016\/j.aca.2009.05.003","journal-title":"Anal Chim Acta"},{"key":"9617_CR40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14756360802632906","volume":"24","author":"M Sun","year":"2009","unstructured":"Sun M, Zheng Y, Wei H, Chen J, Ji M (2009) QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models. J Enzyme Inhib Med Chem 24:1109\u20131116. doi: 10.1080\/14756360802632906","journal-title":"J Enzyme Inhib Med Chem"},{"key":"9617_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00023a004","volume":"35","author":"E Estrada","year":"1995","unstructured":"Estrada E (1995) Edge adjacency relationships and a novel topological index related to molecular volume. J Chem Inf Comput Sci 35:31\u201333. doi: 10.1021\/ci00023a004","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1021\/ci950187r","volume":"36","author":"E Estrada","year":"1996","unstructured":"Estrada E (1996) Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications to the prediction of physical properties of alkanes. J Chem Inf Comput Sci 36:844\u2013849. doi: 10.1021\/ci950187r","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1021\/ci960113v","volume":"37","author":"E Estrada","year":"1997","unstructured":"Estrada E (1997) Spectral moments of the edge-adjacency matrix of molecular graphs. 2. molecules containing heteroatoms and qsar applications. J Chem Inf Comput Sci 37:320\u2013328. doi: 10.1021\/ci960113v","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR44","unstructured":"Gutierrez Y, Estrada E (2002) ModesLab, Version 1.0 www.modeslab.com . Accessed 8 Dec 2014"},{"key":"9617_CR45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger D (1988) Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28:31\u201336. doi: 10.1021\/ci00057a005","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR46","volume-title":"Mobydigs computer software","author":"R Todeschini","year":"2004","unstructured":"Todeschini R, Ballabio D, Consonni V, Mauri A, Pavan M (2004) Mobydigs computer software. Talete, Milano"},{"key":"9617_CR47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-0348-8385-6_4","volume":"55","author":"A Vedani","year":"2000","unstructured":"Vedani A, Dobler M (2000) Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters. Prog Drug Res 55:105\u2013135","journal-title":"Prog Drug Res"},{"key":"9617_CR48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/1381612013397834","volume":"7","author":"A Tropsha","year":"2001","unstructured":"Tropsha A, Zheng W (2001) Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. Curr Pharm Des 7:599\u2013612. doi: 10.2174\/1381612013397834","journal-title":"Curr Pharm Des"},{"key":"9617_CR49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10629360008033231","volume":"11","author":"K Hasegawa","year":"2000","unstructured":"Hasegawa K, Funatsu K (2000) Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships. SAR QSAR Environ Res 11:189\u2013209. doi: 10.1080\/10629360008033231","journal-title":"SAR QSAR Environ Res"},{"key":"9617_CR50","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1021\/ci0501847","volume":"45","author":"MJ Vainio","year":"2005","unstructured":"Vainio MJ, Johnson MS (2005) McQSAR: a multiconformational quantitative structure-activity relationship engine driven by genetic algorithms. J Chem Inf Model 45:1953\u20131961. doi: 10.1021\/ci0501847","journal-title":"J Chem Inf Model"},{"key":"9617_CR51","unstructured":"Klein DJ, Randi\u0107 M, Babi\u0107 D, Lu\u010di\u0107 B, Nikoli\u0107 S, Trinajsti\u0107 N (1997) Hierarchical orthogonalization of descriptors. Int J Quant Chem 63:215\u2013222. doi:10.1002\/(SICI)1097-"},{"key":"9617_CR52","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/ci00025a022","volume":"35","author":"B Lu\u010di\u0107","year":"1995","unstructured":"Lu\u010di\u0107 B, Nikoli\u0107 S, Trinajsti\u0107 N, Juri\u0107 D (1995) The structure-property models can be improved using the orthogonalized descriptors. J Chem Inf Comput Sci 35:532\u2013538. doi: 10.1021\/ci00025a022","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR53","first-page":"517","volume":"15","author":"M Randi\u0107","year":"1991","unstructured":"Randi\u0107 M (1991) Orthogonal molecular descriptors. New J Chem 15:517\u2013525","journal-title":"New J Chem"},{"key":"9617_CR54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/ci00002a018","volume":"31","author":"M Randi\u0107","year":"1991","unstructured":"Randi\u0107 M (1991) Resolution of ambiguities in structure-property studies by use of orthogonal descriptors. J Chem Inf Comput Sci 31:311\u2013320. doi: 10.1021\/ci00002a018","journal-title":"J Chem Inf Comput Sci"},{"key":"9617_CR55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-1280(91)85053-A","volume":"233","author":"M Randi\u0107","year":"1991","unstructured":"Randi\u0107 M (1991) Correlation of enthalpy of octanes with orthogonal connectivity indices. J Mol Struct 233:45\u201359. doi: 10.1016\/0166-1280(91)85053-A","journal-title":"J Mol Struct"},{"key":"9617_CR56","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1289\/ehp.5758","volume":"111","author":"L Eriksson","year":"2003","unstructured":"Eriksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARS. Environ Health Perspect 111:1361\u20131375. doi: 10.1289\/ehp.5758","journal-title":"Environ Health Perspect"},{"key":"9617_CR57","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694\u2013701. doi: 10.1002\/qsar.200610151","journal-title":"QSAR Comb Sci"},{"key":"9617_CR58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/026119290503300209","volume":"33","author":"TI Netzeva","year":"2005","unstructured":"Netzeva TI, Worth A, Aldenberg T, Benigni R, Cronin MT, Gramatica P, Jaworska JS, Kahn S, Klopman G, Marchant CA, Myatt G, Nikolova-Jeliazkova N, Patlewicz GY, Perkins R, Roberts D, Schultz T, Stanton DW, van de Sandt JJ, Tong W, Veith G, Yang C (2005) Current status of methods for defining the applicability domain of (quantitative) structure activity relationships. Altern Lab Anim 33:155\u2013173","journal-title":"Altern Lab Anim"},{"key":"9617_CR59","doi-asserted-by":"crossref","unstructured":"Estrada E, Patlewicz G, Gutierrez Y (2004) From knowledge generation to knowledge archive. A general strategy using TOPS-MODE with DEREK to formulate new alerts for skin sensitization. J Chem Inf Comput Sci 44:688\u2013698. doi: 10.1021\/ci0342425","DOI":"10.1021\/ci0342425"},{"key":"9617_CR60","unstructured":"JChem (2012) ChemAxon www.chemaxon.com . Accessed 8 Sep 2014"},{"key":"9617_CR61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/bioinformatics\/16.5.412","volume":"16","author":"P Baldi","year":"2000","unstructured":"Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H (2000) Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 16:412\u2013424. doi: 10.1093\/bioinformatics\/16.5.412","journal-title":"Bioinformatics"},{"key":"9617_CR62","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jmgm.2006.06.004","volume":"25","author":"AA Ivanov","year":"2007","unstructured":"Ivanov AA, Palyulin VA, Zefirov NS (2007) Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors. J Mol Graph Model 25:740\u2013754. doi: 10.1016\/j.jmgm.2006.06.004","journal-title":"J Mol Graph Model"},{"key":"9617_CR63","doi-asserted-by":"crossref","first-page":"13649","DOI":"10.1021\/ja0697875","volume":"128","author":"N Mills","year":"2006","unstructured":"Mills N (2006) ChemDraw Ultra 10.0. J Am Chem Soc 128:13649\u201313650","journal-title":"J Am Chem Soc"},{"key":"9617_CR64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/026119290503300508","volume":"33","author":"J Jaworska","year":"2005","unstructured":"Jaworska J, Nikolova-Jeliazkova N, Aldenberg T (2005) QSAR applicability domain estimation by projection of the training set descriptor space: a review. Altern Lab Anim 33:445\u2013459","journal-title":"Altern Lab Anim"},{"key":"9617_CR65","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.ejmech.2009.01.009","volume":"44","author":"MH Abraham","year":"2009","unstructured":"Abraham MH, Gil-Lostes J, Fatemi M (2009) Prediction of milk\/plasma concentration ratios of drugs and environmental pollutants. Eur J Med Chem 44:2452\u20132458. doi: 10.1016\/j.ejmech.2009.01.009","journal-title":"Eur J Med Chem"},{"key":"9617_CR66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejmech.2007.04.002","volume":"43","author":"MH Abraham","year":"2008","unstructured":"Abraham MH, Ibrahim A, Acree WE Jr (2008) Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. Eur J Med Chem 43:478\u2013485. doi: 10.1016\/j.ejmech.2007.04.002","journal-title":"Eur J Med Chem"},{"key":"9617_CR67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/ci600402n","volume":"47","author":"C Mintz","year":"2007","unstructured":"Mintz C, Clark M, Acree WE Jr, Abraham MH (2007) Abraham Enthalpy of solvation correlations for gaseous solutes dissolved in water and in 1-octanol based on the Abraham model. J Chem Inf Model 47:115\u2013121. doi: 10.1021\/ci600402n","journal-title":"J Chem Inf Model"},{"key":"9617_CR68","unstructured":"Discovery Studio Visualizer http:\/\/accelrys.com\/products\/discovery-studio\/visualization-download.php . Accessed 8 July 2007"},{"key":"9617_CR69","doi-asserted-by":"crossref","unstructured":"Kim SK, Gao ZG, Jeong LS, Jacobson KA (2006) Docking studies of agonists and antagonists suggest an activation pathway of the $$\\text{ A }_{3}$$ A 3 adenosine receptor. J Mol Graph Model 25:562\u2013577. doi: 10.1016\/j.jmgm.2006.05.004","DOI":"10.1016\/j.jmgm.2006.05.004"},{"key":"9617_CR70","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.bmcl.2008.04.001","volume":"18","author":"A Melman","year":"2008","unstructured":"Melman A, Gao ZG, Kumar D, Wan TC, Gizewski E, Auchampach JA, Jacobson KA (2008) Design of (N)-methanocarba adenosine 5 $$^{\\prime }$$ \u2032 -uronamides as species-independent $$\\text{ A }_{3}$$ A 3 receptor-selective agonists. Bioorg Med Chem Lett 18:2813\u20132819. doi: 10.1016\/j.bmcl.2008.04.001","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9617-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-015-9617-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9617-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T12:40:12Z","timestamp":1566996012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-015-9617-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["9617"],"URL":"https:\/\/doi.org\/10.1007\/s11030-015-9617-z","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}